HSV II

HSV II
Name	Herpes simplex virus type 2
Virus group	dsDNA virus
Family	Herpesviridae
Genus	Simplexvirus
Species	Human herpesvirus 2
Diseases	Genital herpes, neonatal herpes, meningitis

HSV II Herpes simplex virus type 2 is a human pathogenic virus principally associated with genital mucocutaneous infection and neonatal disease. First characterized in mid-20th-century virology studies, it remains a major subject in World Health Organization infectious disease guidance, Centers for Disease Control and Prevention surveillance, and research programs at institutions such as National Institutes of Health and major universities. The virus is closely related to other human herpesviruses studied in clinical contexts like Human herpesvirus 1 research, Varicella zoster virus comparisons, and antiviral development driven by pharmaceutical firms and public health agencies.

Virology

HSV II is a double-stranded DNA virus in the family Herpesviridae and genus Simplexvirus, sharing genomic architecture with Human herpesvirus 1 and divergent strains described in molecular studies at places like Cold Spring Harbor Laboratory and Wellcome Trust Sanger Institute. The viral particle comprises an icosahedral capsid, tegument proteins—investigated in structural biology at Max Planck Institute laboratories—and a lipid envelope embedded with glycoproteins (gB, gD, gH/gL) that interact with host receptors characterized by researchers at Johns Hopkins University and University of Oxford. Latency is established in sensory neurons of the dorsal root ganglia, a phenomenon probed using techniques developed at Harvard Medical School and visualized in models from Salk Institute. Genomic sequencing projects led by Broad Institute have detailed gene content and diversity, informing phylogenetic work published in journals affiliated with American Society for Microbiology.

Epidemiology

Global prevalence estimates from World Health Organization reports and national surveillance by agencies such as Public Health England and the Centers for Disease Control and Prevention indicate high seroprevalence in many regions, with demographic patterns reported in cohort studies from institutions like University of Cape Town and Imperial College London. Epidemics and cross-sectional surveys in settings including Sub-Saharan Africa, Southeast Asia, and metropolitan centers such as New York City and Los Angeles have documented age-related seroconversion, with burden assessed in epidemiologic reviews in journals associated with The Lancet and New England Journal of Medicine. Socioeconomic and population studies by researchers at Columbia University and University of California, San Francisco examine risk factors, while modeling groups at London School of Hygiene & Tropical Medicine project incidence trends.

Transmission and Pathophysiology

Transmission occurs primarily through sexual contact involving mucosal surfaces, described in behavioral studies from Kinsey Institute datasets and public health messaging from UNAIDS and Planned Parenthood. Vertical transmission during delivery, documented in obstetrics literature from American College of Obstetricians and Gynecologists, can result in neonatal herpes with high morbidity. At the cellular level, viral entry is mediated by glycoprotein-receptor interactions studied in basic science labs at Massachusetts Institute of Technology and University of Pennsylvania, leading to membrane fusion, intracellular trafficking to the nucleus, and latency establishment in neurons researched within neuroscience centers at UCSF and Stanford University. Reactivation triggers have been explored in immunology work from Rockefeller University and stress-response studies connected to National Institute of Mental Health research.

Clinical Presentation

Primary genital infection frequently presents with vesicular lesions, dysuria, and systemic symptoms described in clinical guidelines from British Association for Sexual Health and HIV and Infectious Diseases Society of America. Recurrent lesions are typical, with prodromal sensory signs documented in case series from Mayo Clinic and Cleveland Clinic. Complications include aseptic meningitis reported in neurology services at Mount Sinai Hospital and disseminated infection in immunocompromised patients managed in centers like MD Anderson Cancer Center. Neonatal HSV acquired perinatally can cause cutaneous, central nervous system, or disseminated disease detailed in pediatric protocols from American Academy of Pediatrics.

Diagnosis

Diagnosis relies on direct detection by polymerase chain reaction assays standardized in laboratories accredited by College of American Pathologists and viral culture techniques used historically in reference labs such as CDC and university clinical virology units at University of Michigan. Type-specific serology distinguishing antibodies to glycoprotein G is available from commercial diagnostics developed by firms like Abbott Laboratories and validated in studies published in journals affiliated with Clinical Infectious Diseases. Point-of-care rapid tests and nucleic acid amplification testing are implemented in sexual health clinics following guidance from World Health Organization and national public health agencies.

Treatment and Management

Antiviral therapy using nucleoside analogues such as acyclovir, valacyclovir, and famciclovir—developed through programs involving companies like GlaxoSmithKline and Merck & Co.—reduces symptoms, viral shedding, and recurrence frequency, with dosing recommendations in guidelines from Infectious Diseases Society of America and European Medicines Agency. Suppressive therapy is indicated for frequent recurrences; episodic therapy is used for mild disease as described in clinical trials at University College London and Duke University Medical Center. Management of neonatal HSV requires intravenous antiviral protocols established in pediatric infectious disease centers such as Children's Hospital of Philadelphia. Emerging strategies include vaccine research pursued by consortia involving NIH and biotech firms, and novel antivirals evaluated in randomized trials registered with Food and Drug Administration oversight.

Prevention and Public Health

Prevention strategies combine behavioral interventions promoted by UNAIDS and Planned Parenthood, condom use recommendations from Centers for Disease Control and Prevention, antenatal screening policies debated in obstetric organizations like Royal College of Obstetricians and Gynaecologists, and peripartum management to reduce neonatal transmission. Public health surveillance and education campaigns are delivered through health departments in municipalities such as Chicago and Sydney and coordinated by international bodies including World Health Organization and Pan American Health Organization. Vaccine development, microbicide research, and combination prevention approaches are active priorities for funders including Bill & Melinda Gates Foundation and research networks affiliated with Global Virus Network.

Category:Human herpesviruses